M&A Deal Summary

Callitas Therapeutics Acquires ToConceive

On October 6, 2016, Callitas Therapeutics acquired life science company ToConceive

Acquisition Highlights
  • This is Callitas Therapeutics’ 2nd transaction in the Life Science sector.
  • This is Callitas Therapeutics’ 2nd transaction in the United States.
  • This is Callitas Therapeutics’ 1st transaction in Kentucky.

M&A Deal Summary
Date 2016-10-06
Target ToConceive
Sector Life Science
Buyer(s) Callitas Therapeutics
Deal Type Add-on Acquisition

Target

ToConceive

Ft. Thomas, Kentucky, United States
ToConceive LLC is a private pharmaceutical company develops a natural conception lubrication to getting pregnant.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Callitas Therapeutics

Vancouver, British Columbia, Canada
Category Company
Founded 2003
Sector Healthcare Services
Revenue 1M CAD (2017)
DESCRIPTION

Callitas Health is focuses on providing biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes. Callitas Health was founded in 2003 and is based in Vancouver, Canada.

DEAL STATS #
Overall 4 of 4
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 3 of 3
State (Kentucky) 1 of 1
Country (United States) 2 of 2
Year (2016) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-01 Chelatexx - Reformulated Orlistat For Weight Loss

United States

Chelatexx - Reformulated Orlistat For Weight Loss comprises a weight loss pharmaceutical product. The asset is located in the United States.

Buy -
Mergr

Product

Company

Legal